Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Medical Genetics Unit, |
RCV001283731 | SCV001423581 | pathogenic | Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection | 2020-04-24 | criteria provided, single submitter | case-control | The p.Leu79Ter variant in IFNAR2 gene has been identified in a compound heterozygous status with a frameshift variant in a patient with high fever and lethargy after live-attenuated MMR (measles-mumps-rubella) vaccine and was absent from large population studies. Additionally, ex vivo functional studies indicate that the Leu79Ter variant causes an impairment of type I IFN-mediated responses (Passarelli, submitted). In summary, the Leu79Ter variant meets our criteria to be classified as pathogenic based upon segregation studies, absence from controls and functional evidence. |
Labcorp Genetics |
RCV001879919 | SCV002238764 | pathogenic | not provided | 2022-08-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu79*) in the IFNAR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFNAR2 are known to be pathogenic (PMID: 26424569, 33193576). This variant is present in population databases (no rsID available, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with hemophagocytic lymphohistiocytosis (PMID: 33193576). This variant is also known as c.234delT. ClinVar contains an entry for this variant (Variation ID: 977219). For these reasons, this variant has been classified as Pathogenic. |
Department of Pathology and Laboratory Medicine, |
RCV001780205 | SCV005918549 | likely pathogenic | Immunodeficiency 45 | 2023-04-24 | criteria provided, single submitter | research | |
OMIM | RCV001780205 | SCV002025263 | pathogenic | Immunodeficiency 45 | 2021-11-19 | no assertion criteria provided | literature only |